DESENVOLVIMENTO DE ÍNDICE PROGNÓSTICO PARA PACIENTES ADULTOS COM LEUCEMIA LINFOBLÁSTICA AGUDA NA REALIDADE NACIONAL

Autor: EC Chapchap, AL Oliveira, MEAJ Cavalho, PEM Flores, VAQ Mauad, D Borducchi, FR Kerbauy, N Hamerschlak

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S241- (2023)

A Leucemia linfoblástica aguda (LLA) está associada a menor sobrevida global (SG) e livre de progressão (SLP) em adultos devido a múltiplos fatores de risco e menor tolerância aos protocolos de quimioterapia. A estratificação prognóstica infl

Externí odkaz: https://doaj.org/article/86035ec28b76494a878d1ed2484abe02

INCORPORAÇÃO DE NOVOS FATORES DE RISCO AO IPI PARA REFINAR A ESTRATIFICAÇÃO PROGNÓSTICA DE PACIENTES HIV-POSITIVOS COM DIAGNÓSTICO DE LINFOMA NÃO-HODGKIN

Autor: JC Vargas, EC Chapchap, AL Oliveira, JD Rocha, FGB Chaves, GF Perini, O Baiocchi, J Pererira, N Hamerschlak

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S364- (2023)

Introdução: Os avanços na terapia antirretroviral (TARV) melhoraram o prognóstico de pacientes HIV positivos em curso de quimioterapia, porém os linfomas não Hodgkin (LNH) ainda afetam a mortalidade. O manejo de pacientes HIV-positivos com linf

Externí odkaz: https://doaj.org/article/754df8b9e8d34bcaad2a244040434b38

Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms.

Autor: Celades C; Lymphoid Neoplasms Group, Josep Carreras Laukaemia Research Institute, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Tuset M; Pharmacy Department, Division of Medicines, Hospital Clinic-Fundació de recerca Clinic Barcelona-Institut de investigacions Biomediques August Pi i Sunyer, Barcelona, Spain., Ambrosioni J; HIV Unit, Infectious Diseases Department, Hospital Clinic-Fundació de recerca Clinic Barcelona-Institut de investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Calvo J; HIV Unit, Infectious Diseases Department, Hospital Clinic-Fundació de recerca Clinic Barcelona-Institut de investigacions Biomediques August Pi i Sunyer, Barcelona, Spain., Lizondo T; Pharmacy Department, Division of Medicines, Hospital Clinic Barcelona, Barcelona, Spain., Sabato S; Fundació Lluita Contra les Infeccions, Infectious Diseases Department, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain., Guardia A; Hematology Department, Hospital Clinic-Fundació de recerca Clinic Barcelona-Institut de investigacions Biomediques August Pi i Sunyer, Barcelona, Spain., Chapchap EC; Hematology Center, Albert Einstein Israelit Hospital, Sao Paulo, Brazil., Navarro JT; Lymphoid Neoplasms Group, Josep Carreras Laukaemia Research Institute, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Institut Cataalà d'Oncologia-Germans Trias i Pujol Hospital, Badalona, Spain., Molto J; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Fundació Lluita Contra les Infeccions, Infectious Diseases Department, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 01; Vol. 79 (10), pp. 2493-2499.

Extramedullary haematopoiesis in patients with thalassemia: a cross-sectional description of its prevalence, clinical features and survival.

Autor: Chapchap EC; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. Electronic address: eduardo.cerello@einstein.br., Silva MMA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Baroni RH; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Araujo ADS; Fundação de Hematologia e Hemoterapia de Pernambuco (Hemope), Recife, PE, Brazil., de Assis RA; Fundação de Hematologia e Hemoterapia de Pernambuco (Hemope), Recife, PE, Brazil., Loggetto SR; Centro de Hematologia de São Paulo, São Paulo, SP, Brazil., Junior AF; Hemocentro de Marília, Marília, SP, Brazil., Verissimo MPA; Centro Infantil Boldrini, Campinas, SP, Brazil., Baldanzi GR; Centro de Hematologia e Hemoterapia do Paraná - HEMEPAR, Curitiba, PR, Brazil., Fertrin KY; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA., Tricta F; Medical Affairs, ApoPharma, Toronto, CA, Canada., Piga AG; Department of Clinical and Biological Sciences, University of Turin, Italy., Hamerschlak N; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2023 Aug 26. Date of Electronic Publication: 2023 Aug 26.

Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study.

Autor: Chapchap EC; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Silva MMA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., de Assis RA; Fundação de Hematologia e Hemoterapia de Pernambuco (HEMOPE), Recife, PE, Brazil., Kerbauy LN; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Diniz MDS; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Rosemberg LA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Loggetto SR; Hospital Infantil Sabará, São Paulo, SP, Brazil., Araujo ADS; Fundação de Hematologia e Hemoterapia de Pernambuco (HEMOPE), Recife, PE, Brazil., Fabron Junior A; Hemocentro de Marília, Marília, SP, Brazil., Verissimo MPA; Centro de Pesquisa Boldrini Campinas, SP, Brazil., Baldanzi GR; Centro de Hematologia e Hemoterapia do Paraná (HEMOPAR), Curitiba, PR, Brazil., Esposito BP; Instituto de Química, Universidade de São Paulo (USP), São Paulo, SP, Brazil., Tricta F; Clinical Trials Department Apotex, Toronto, Canada., Steagall MEA; Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, SP, Brazil., Vellozo CÂGDS; Associação Brasileira de Linfoma e Leucemia (ABRASTA), São Paulo, SP, Brazil., Fertrin KY; Universidade de Campinas (UNICAMP), Campinas, SP, Brazil., Baroni RH; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Hamerschlak N; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. Electronic address: hamer@einstein.br.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2023 Jan-Mar; Vol. 45 (1), pp. 7-15. Date of Electronic Publication: 2021 May 09.